αααααβααΎαHLUN-A β’ CPH
add
H. Lundbeck A/S Class A
35.95Β kr
28 αα·α
ααα·ααΆ, 10:37:07 AM ααααβααα +1 · DKK · CPH · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΆααα»αααααΆααααααααΆααα·ααααΆαααΌααααααααααΆαα
α»ααααααΈαα
DK
αα·αααΈαα»α
35.95Β kr
α
αααααααααααα
35.80Β kr - 35.95Β kr
α
ααααααα½αααααΆαα
α»αααααα
27.10Β kr - 41.70Β kr
ααΎαβαα»αβααΈααααΆα
43.04Β αααΈααΆα DKK
ααα ααα½αααΌαααααα
62.23Β ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
CPH
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(DKK) | αααααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 5.72Β αααΈααΆα | 15.55% |
α
αααΆαααααα·ααααα·ααΆα | 3.67Β αααΈααΆα | 23.76% |
α
αααΌααα»ααα | 777.00Β ααΆα | 14.94% |
ααααΆααα
αααααα»ααα | 13.58 | -0.51% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 1.30 | 11.11% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 1.43Β αααΈααΆα | 3.10% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -6.15% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(DKK) | αααααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 8.32Β αααΈααΆα | 95.90% |
ααααααααα»α | 39.52Β αααΈααΆα | 4.89% |
ααΆαααα½ααα»αααααΌαααα»α | 15.68Β αααΈααΆα | 2.04% |
ααΌαβααααα»α | 23.84Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 996.15Β ααΆα | β |
ααααααααααΉαααααα
| 1.50 | β |
ααα
ααααααΎαααααα | 6.11% | β |
ααα
ααααααΎααΎααα»α | 8.67% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(DKK) | αααααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | 777.00Β ααΆα | 14.94% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 2.30Β αααΈααΆα | 54.50% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -101.00Β ααΆα | -4.12% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -24.00Β ααΆα | 97.05% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 2.17Β αααΈααΆα | 270.77% |
ααα αΌαααΆα
αααααΆααααααα | 985.25Β ααΆα | -28.86% |
α’αααΈ
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The companyβs products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
ααΆααααααΎαα‘αΎα
14 ααΈα αΆ 1915
αααααβαααααΆα
αα»ααααα·α
5,500